 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || F61 injection / Sinopharm
New P1 trial: Clinical Study of F61 Injection in Healthy Chinese Subjects (clinicaltrials.gov) - Aug 2, 2022
P1, N=40, Not yet recruiting, Sponsor: Wuhan Institute of Biological Products Co., Ltd